Guzman Sanchez-Schmitz, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Monocytes | 9 | 2021 | 2570 | 1.050 |
Why?
|
| BCG Vaccine | 4 | 2021 | 369 | 0.920 |
Why?
|
| Hepatitis B Vaccines | 1 | 2018 | 178 | 0.580 |
Why?
|
| Dendritic Cells | 7 | 2018 | 2747 | 0.560 |
Why?
|
| Cell Movement | 5 | 2020 | 5205 | 0.360 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2018 | 4369 | 0.350 |
Why?
|
| Endothelium, Vascular | 3 | 2020 | 4431 | 0.350 |
Why?
|
| Homeostasis | 1 | 2020 | 3323 | 0.330 |
Why?
|
| Immune System | 1 | 2011 | 796 | 0.260 |
Why?
|
| Vaccines | 2 | 2011 | 844 | 0.250 |
Why?
|
| Infant, Newborn | 7 | 2021 | 26198 | 0.240 |
Why?
|
| Models, Biological | 1 | 2020 | 9469 | 0.230 |
Why?
|
| Adjuvants, Immunologic | 3 | 2018 | 1036 | 0.220 |
Why?
|
| Receptors, IgG | 2 | 2002 | 559 | 0.190 |
Why?
|
| Immunity, Innate | 4 | 2021 | 3066 | 0.190 |
Why?
|
| Immunophenotyping | 3 | 2020 | 1869 | 0.190 |
Why?
|
| Aging | 1 | 2018 | 8711 | 0.170 |
Why?
|
| Microbial Viability | 1 | 2020 | 238 | 0.160 |
Why?
|
| Models, Immunological | 3 | 2010 | 513 | 0.150 |
Why?
|
| RNA, Bacterial | 1 | 2020 | 393 | 0.150 |
Why?
|
| Tissue Engineering | 2 | 2023 | 1868 | 0.150 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 290 | 0.150 |
Why?
|
| Cytokines | 7 | 2021 | 7396 | 0.140 |
Why?
|
| Hydrogels | 1 | 2023 | 720 | 0.140 |
Why?
|
| Leprosy | 1 | 2016 | 126 | 0.140 |
Why?
|
| Immunologic Memory | 2 | 2021 | 1359 | 0.130 |
Why?
|
| Homozygote | 1 | 2020 | 1776 | 0.130 |
Why?
|
| Immunization | 1 | 2018 | 1227 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2020 | 3088 | 0.110 |
Why?
|
| Indians, North American | 1 | 2016 | 352 | 0.110 |
Why?
|
| Imidazoles | 2 | 2017 | 1180 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2020 | 2665 | 0.100 |
Why?
|
| Quinolines | 1 | 2017 | 765 | 0.100 |
Why?
|
| HLA Antigens | 1 | 2016 | 1328 | 0.090 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 5485 | 0.090 |
Why?
|
| Animal Testing Alternatives | 1 | 2009 | 15 | 0.090 |
Why?
|
| Lymphoid Tissue | 1 | 2009 | 445 | 0.070 |
Why?
|
| Child Development | 1 | 2019 | 2306 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3801 | 0.070 |
Why?
|
| Antigen Presentation | 2 | 2010 | 1251 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 589 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2017 | 1958 | 0.060 |
Why?
|
| Zymosan | 2 | 2002 | 134 | 0.060 |
Why?
|
| Communicable Disease Control | 1 | 2011 | 846 | 0.060 |
Why?
|
| Vaccination | 2 | 2017 | 3384 | 0.050 |
Why?
|
| Receptors, CCR7 | 3 | 2010 | 107 | 0.050 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2001 | 509 | 0.050 |
Why?
|
| Leukocytes | 1 | 2009 | 2026 | 0.050 |
Why?
|
| Adult | 5 | 2020 | 221200 | 0.050 |
Why?
|
| Inflammation | 1 | 2020 | 10774 | 0.050 |
Why?
|
| Entamoeba histolytica | 1 | 2000 | 29 | 0.040 |
Why?
|
| Bulgaria | 1 | 2020 | 17 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2010 | 11530 | 0.040 |
Why?
|
| Dextrans | 1 | 2001 | 574 | 0.040 |
Why?
|
| Papua New Guinea | 1 | 2019 | 46 | 0.040 |
Why?
|
| Isoantigens | 1 | 2001 | 551 | 0.040 |
Why?
|
| Mycobacterium bovis | 1 | 2020 | 147 | 0.040 |
Why?
|
| Gambia | 1 | 2019 | 104 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2010 | 2206 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2023 | 1848 | 0.040 |
Why?
|
| Humans | 15 | 2021 | 761578 | 0.040 |
Why?
|
| Denmark | 1 | 2020 | 771 | 0.040 |
Why?
|
| Autoantigens | 1 | 2001 | 891 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2023 | 1152 | 0.030 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2017 | 99 | 0.030 |
Why?
|
| Cell Separation | 1 | 2001 | 1720 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2023 | 934 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2001 | 1528 | 0.030 |
Why?
|
| Biomimetics | 1 | 2017 | 171 | 0.030 |
Why?
|
| Japan | 1 | 2020 | 1378 | 0.030 |
Why?
|
| Systems Biology | 1 | 2019 | 481 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2023 | 1726 | 0.030 |
Why?
|
| Chemokines | 1 | 2019 | 959 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 764 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2017 | 18966 | 0.030 |
Why?
|
| India | 1 | 2020 | 2348 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2004 | 3466 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 2 | 2010 | 964 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2017 | 549 | 0.030 |
Why?
|
| Animals | 7 | 2023 | 168475 | 0.030 |
Why?
|
| Swine | 1 | 2023 | 5915 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 726 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2017 | 2626 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 2020 | 0.020 |
Why?
|
| Receptors, Chemokine | 2 | 2005 | 652 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2017 | 2677 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 4352 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2000 | 4125 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2016 | 2601 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 2010 | 107 | 0.020 |
Why?
|
| Poly I-C | 1 | 2010 | 112 | 0.020 |
Why?
|
| Polymers | 1 | 2017 | 1616 | 0.020 |
Why?
|
| Tetanus Toxin | 1 | 2009 | 46 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2016 | 3606 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 2010 | 189 | 0.020 |
Why?
|
| Metabolomics | 1 | 2019 | 1659 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 5790 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 42231 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2010 | 779 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2735 | 0.020 |
Why?
|
| Middle Aged | 2 | 2018 | 220917 | 0.020 |
Why?
|
| Antigens, CD | 2 | 2010 | 4001 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 17904 | 0.020 |
Why?
|
| Rats | 1 | 2023 | 23741 | 0.020 |
Why?
|
| Male | 3 | 2020 | 360841 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 4243 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 1341 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 6864 | 0.020 |
Why?
|
| Female | 3 | 2020 | 392688 | 0.020 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2005 | 38 | 0.020 |
Why?
|
| Proteomics | 1 | 2019 | 3848 | 0.020 |
Why?
|
| Receptors, CCR8 | 1 | 2004 | 28 | 0.020 |
Why?
|
| Leukotriene C4 | 1 | 2005 | 79 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1334 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2009 | 1154 | 0.010 |
Why?
|
| High-Throughput Screening Assays | 1 | 2009 | 934 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 22173 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2009 | 1469 | 0.010 |
Why?
|
| Lymphatic System | 1 | 2005 | 254 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2010 | 1844 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9420 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2005 | 597 | 0.010 |
Why?
|
| Microspheres | 1 | 2004 | 784 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 1646 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 2002 | 602 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 2820 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 2000 | 255 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22176 | 0.010 |
Why?
|
| Mice | 3 | 2017 | 81539 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2002 | 629 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 4544 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 1486 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4576 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3549 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 4758 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2005 | 2490 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 41493 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2002 | 1964 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 2898 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5870 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 3701 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 8002 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 10194 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 5791 | 0.010 |
Why?
|
| United States | 1 | 2020 | 72335 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 4484 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2002 | 3397 | 0.010 |
Why?
|
| Macrophages | 1 | 2005 | 5767 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 169308 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2005 | 23447 | 0.000 |
Why?
|